EASTWOOD BIO-MEDICAL CANADA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.88 CAD | +27.54% |
|
+27.54% | +60.00% |
Valuation
| Fiscal Period: October | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 442.9 | 62 | 172.2 | 100.6 | 86.11 | 55.11 |
| Enterprise Value (EV) 1 | 442.1 | 61.37 | 172.1 | 100.6 | 86.13 | 55.15 |
| P/E ratio | -514 x | -107 x | -202 x | -167 x | -575 x | -101 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 595 x | 48 x | 240 x | 103 x | 66.2 x | 63.5 x |
| EV / Revenue | 594 x | 47.5 x | 240 x | 103 x | 66.3 x | 63.5 x |
| EV / EBITDA | -847 x | -131 x | -190 x | -192 x | -1,332 x | -130 x |
| EV / FCF | 1,181 x | 91.1 x | -663 x | 916 x | 5,709 x | 314 x |
| FCF Yield | 0.08% | 1.1% | -0.15% | 0.11% | 0.02% | 0.32% |
| Price to Book | 234 x | 47.3 x | 375 x | -697 x | -293 x | -65.5 x |
| Nbr of stocks (in thousands) | 68,886 | 68,886 | 68,886 | 68,886 | 68,886 | 68,886 |
| Reference price 2 | 6.430 | 0.9000 | 2.500 | 1.460 | 1.250 | 0.8000 |
| Announcement Date | 2/28/19 | 2/26/20 | 3/1/21 | 2/28/22 | 2/28/23 | 2/28/24 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: October | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.744 | 1.293 | 0.7183 | 0.9811 | 1.3 | 0.8679 |
| EBITDA 1 | -0.5222 | -0.4691 | -0.9039 | -0.5241 | -0.0646 | -0.4242 |
| EBIT 1 | -0.5478 | -0.5151 | -0.9499 | -0.5697 | -0.1117 | -0.4723 |
| Operating Margin | -73.63% | -39.84% | -132.23% | -58.07% | -8.6% | -54.42% |
| Earnings before Tax (EBT) 1 | -0.862 | -0.5773 | -0.8524 | -0.6036 | -0.1499 | -0.5466 |
| Net income 1 | -0.862 | -0.5773 | -0.8524 | -0.6036 | -0.1499 | -0.5466 |
| Net margin | -115.86% | -44.65% | -118.67% | -61.53% | -11.53% | -62.98% |
| EPS 2 | -0.0125 | -0.008380 | -0.0124 | -0.008762 | -0.002175 | -0.007934 |
| Free Cash Flow 1 | 0.3742 | 0.6734 | -0.2596 | 0.1098 | 0.0151 | 0.1756 |
| FCF margin | 50.3% | 52.09% | -36.14% | 11.19% | 1.16% | 20.24% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 2/28/19 | 2/26/20 | 3/1/21 | 2/28/22 | 2/28/23 | 2/28/24 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: October | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 0.01 | 0.02 | 0.04 |
| Net Cash position 1 | 0.83 | 0.63 | 0.1 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | -0.02 x | -0.3467 x | -0.1026 x |
| Free Cash Flow 1 | 0.37 | 0.67 | -0.26 | 0.11 | 0.02 | 0.18 |
| ROE (net income / shareholders' equity) | -37.1% | -36.1% | -96.3% | -383% | 68.4% | 96.3% |
| ROA (Net income/ Total Assets) | -13.5% | -16.5% | -46% | -43.8% | -10.9% | -55% |
| Assets 1 | 6.38 | 3.495 | 1.853 | 1.377 | 1.369 | 0.994 |
| Book Value Per Share 2 | 0.0300 | 0.0200 | 0.0100 | -0 | -0 | -0.0100 |
| Cash Flow per Share 2 | 0.0100 | 0.0100 | 0 | 0 | 0 | 0 |
| Capex | - | 0.02 | - | 0.01 | 0 | - |
| Capex / Sales | - | 1.79% | - | 0.57% | 0.23% | - |
| Announcement Date | 2/28/19 | 2/26/20 | 3/1/21 | 2/28/22 | 2/28/23 | 2/28/24 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +60.00% | 44.28M | |
| +35.04% | 5.92B | |
| -15.13% | 4.51B | |
| -9.75% | 3.15B | |
| +2.14% | 3.1B | |
| -6.82% | 2.42B | |
| +47.87% | 1.97B | |
| -7.89% | 1.68B | |
| +0.09% | 1.65B | |
| -12.97% | 1.53B |
- Stock Market
- Equities
- EBM Stock
- Financials Eastwood Bio-Medical Canada Inc.
